The blockbuster weight-loss and diabetes drug Ozempic (Semaglutide) is set to become affordable for the common man in India. With the patent for Semaglutide expiring on March 20, 2026, Indian pharma ...

Sending a "strong message" that the Supreme Court is meant for the common man, Chief Justice of India Surya Kant on Saturday said a predictable timeline and a unified national judicial policy-based ...